AN2 Therapeutics Inc (ANTX)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics Price: 1.34 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 1.26 | 1.419 | 1.26 | 1.34 | 1.250M |
| Nov 21, 2024 | 1.30 | 1.46 | 1.20 | 1.23 | 3.803M |
| Nov 20, 2024 | 1.07 | 1.33 | 1.07 | 1.30 | 5.553M |
| Nov 19, 2024 | 1.03 | 1.11 | 1.00 | 1.06 | 2.079M |
| Nov 18, 2024 | 1.00 | 1.03 | 0.975 | 1.00 | 726207.0 |
| Nov 15, 2024 | 1.00 | 1.04 | 0.9945 | 1.00 | 1.247M |
| Nov 14, 2024 | 1.03 | 1.03 | 0.9933 | 1.00 | 697979.0 |
| Nov 13, 2024 | 1.06 | 1.07 | 0.99 | 1.01 | 1.319M |
| Nov 12, 2024 | 1.08 | 1.105 | 1.05 | 1.06 | 475458.0 |
| Nov 11, 2024 | 1.11 | 1.12 | 1.08 | 1.09 | 1.107M |
| Nov 08, 2024 | 1.11 | 1.12 | 1.09 | 1.10 | 868018.0 |
| Nov 07, 2024 | 1.10 | 1.11 | 1.10 | 1.10 | 54584.00 |
| Nov 06, 2024 | 1.10 | 1.11 | 1.09 | 1.10 | 105508.0 |
| Nov 05, 2024 | 1.09 | 1.10 | 1.08 | 1.09 | 114741.0 |
| Nov 04, 2024 | 1.08 | 1.09 | 1.07 | 1.08 | 138410.0 |
| Nov 01, 2024 | 1.09 | 1.091 | 1.08 | 1.08 | 132451.0 |
| Oct 31, 2024 | 1.08 | 1.10 | 1.075 | 1.08 | 119072.0 |
| Oct 30, 2024 | 1.12 | 1.12 | 1.080 | 1.09 | 140179.0 |
| Oct 29, 2024 | 1.10 | 1.14 | 1.09 | 1.11 | 256467.0 |
| Oct 28, 2024 | 1.09 | 1.12 | 1.072 | 1.10 | 269696.0 |
| Oct 25, 2024 | 1.07 | 1.08 | 1.06 | 1.07 | 64860.00 |
| Oct 24, 2024 | 1.09 | 1.09 | 1.07 | 1.07 | 97763.00 |
| Oct 23, 2024 | 1.08 | 1.09 | 1.06 | 1.08 | 133466.0 |
| Oct 22, 2024 | 1.07 | 1.10 | 1.06 | 1.08 | 178807.0 |
| Oct 21, 2024 | 1.06 | 1.12 | 1.06 | 1.08 | 631163.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.98
Minimum
Aug 16 2024
22.29
Maximum
Aug 15 2022
9.472
Average
8.99
Median
Jul 08 2022
Price Benchmarks
| Biomarin Pharmaceutical Inc | 64.26 |
| Arbutus Biopharma Corp | 3.51 |
| GlycoMimetics Inc | 0.3168 |
| FibroGen Inc | 0.3954 |
| Cidara Therapeutics Inc | 20.40 |
Price Related Metrics
| Price to Book Value | 0.4567 |
| Earnings Yield | -152.2% |
| Market Cap | 40.04M |